the applied asa dose ( mean dose 150 mg ) elicited bronchoconstriction in all 16 patients with asthma and asa sensitivity ( mean fall of fev1 34 % ) and increased the weal response to compound 48/80 to about 51 % ( p less than 0.05 ) as compared with the response before the asa-challenge .
C0004096
asthma
C0004057
asa